LicianPro

Inhibitor Therapeutics, Inc. ·

INTI 8-K 2026-09-18

Inhibitor Therapeutics, Inc. (INTI) 8-K dated 2026-09-18 — accession 0001493152-26-043331.

Inhibitor Therapeutics, Inc. (INTI) is a biotechnology company listed on US.

Inhibitor Therapeutics, Inc. filed a 8-K on 2026-09-18. Accession 0001493152-26-043331.

This 8-K covers: Director/officer change (Item 5.02), Shareholder vote results (Item 5.07). SEC EDGAR holds the official filing and its exhibits.

Latest reported INTI revenue for 2021-12-31 was $0. Net income was -$298.6K. INTI currently screens at market cap $13.3M.

Not investment advice. The INTI SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr